Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 12.96
- Piotroski Score 6.00
- Grade Sector Outperform
- Symbol (TECH)
- Company Bio-Techne Corporation
- Price $71.07
- Changes Percentage (3.42%)
- Change $2.35
- Day Low $68.42
- Day High $71.32
- Year High $85.57
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
- Last Earnings 10/30/2024
- Ex-Dividend for 5/16 Dividend 11/08/2024
- Dividend Payable 11/22/2024
- Today N/A
- Next Earnings (Estimated) 01/30/2025
- Fiscal Year End N/A
- Average Stock Price Target $90.75
- High Stock Price Target $105.00
- Low Stock Price Target $80.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.25
- Trailing P/E Ratio 62.1
- Forward P/E Ratio 62.1
- P/E Growth 62.1
- Net Income $168.11 M
Income Statement
Quarterly
Annual
Latest News of TECH
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is SolarEdge Technologies (SEDG) The Best Climate Change Stock To Invest In Right Now?
Hedge funds are betting against the green economy despite global investments in clean energy. Solar, EV, and battery sectors face skepticism, while fossil fuels gain favor due to perceived profitabili...
By Yahoo! Finance | 23 hours ago -
Is Array Technologies (ARRY) The Best Climate Change Stock To Invest In Right Now?
A recent article discusses the climate change impact on 2023, highlighting record-breaking greenhouse gas emissions, rising sea levels, extreme weather events, and global temperature increase....
By Yahoo! Finance | 23 hours ago -
CFPB Gives Itself Oversight of Big Tech's Digital Payment Apps
The Consumer Financial Protection Bureau has approved a rule to regulate big tech firms like Apple and Google, as well as financial technology companies like PayPal and Cash App. These companies have ...
By Yahoo! Finance | 23 hours ago
